Trial Profile
Phase Ib trial of taladegib in solid tumours
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Taladegib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 10 May 2016 According to an Ignyta media release, company is expected to initiate this trial in the third quarter of 2016.
- 13 Jan 2016 New trial record